Jump to content

Quinfamide

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by SporkBot (talk | contribs) at 02:41, 7 April 2016 (Repair duplicate template arguments). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Quinfamide
Clinical data
Routes of
administration
Oral
ATC code
  • None
Identifiers
  • [1-(2,2-dichloroacetyl)-3,4-dihydro-2H-quinolin-6-yl] furan-2-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.057.690 Edit this at Wikidata
Chemical and physical data
FormulaC16H13Cl2NO4
Molar mass354.18472 g/mol g·mol−1
3D model (JSmol)
  • C1CC2=C(C=CC(=C2)OC(=O)C3=CC=CO3)N(C1)C(=O)C(Cl)Cl
  • InChI=1S/C16H13Cl2NO4/c17-14(18)15(20)19-7-1-3-10-9-11(5-6-12(10)19)23-16(21)13-4-2-8-22-13/h2,4-6,8-9,14H,1,3,7H2 ☒N
  • Key:SBJGFIXQRZOVTO-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Quinfamide, is a drug that has anti-parasitic properties.[1]

Synthesis

Quinfamide is one of a relatively small family of antiamoebic compounds containing a dichloroacetamide function.

Quinfamide synthesis:[2][3]

The synthesis begins by amidation of 6-hydroxytetrahydroquinoline with dichloroacetyl chloride. The sequence is completed by acylation with 2-furoyl chloride.

References

  1. ^ Davila-Gutierrez, CE.; Vasquez, C.; Trujillo-Hernandez, B.; Huerta, M. (Mar 2002). "Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children". Am J Trop Med Hyg. 66 (3): 251–4. PMID 12139216.
  2. ^ D. M. Bailey, U.S. patent 3,997,542 (1976 to Sterling).
  3. ^ Bailey, Denis M.; Mount, Eldridge M.; Siggins, James; Carlson, John A.; Yarinsky, Allen; Slighter, Ralph G. (1979). "1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol esters. New potent antiamebic agents". Journal of Medicinal Chemistry. 22 (5): 599. doi:10.1021/jm00191a031. PMID 458814.